27.06.2013 Views

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

tel-00827710, version 1 - 29 May 2013<br />

were pooled for our analysis. CD11c + cells were enriched using CD11c magn<strong>et</strong>ic beads<br />

(Miltenyi Biotech), and the enriched fraction was analyzed by flow cytom<strong>et</strong>ry to i<strong>de</strong>ntify the<br />

different subs<strong>et</strong>s of DCs present. In parallel, the flow-through fraction was stained to i<strong>de</strong>ntify<br />

the different populations of cells stained with the PKH26 dye.<br />

IV. CHARACTERIZATION OF ANTIGEN PERSISTENCE<br />

A. Persistence of antigen cross-presentation<br />

CD45.1 OT-I splenocytes were isolated and stained using 5µM carboxyfluorescein diac<strong>et</strong>ate<br />

succinimidyl ester (CSFE) in PBS. After washing with ice-cold PBS, 5x10 6 OT-I splenocytes<br />

were injected i.v. into immunized mice. Three days later the draining and non-draining lymph<br />

no<strong>de</strong>s, and the spleen were harvested. Organs were processed in<strong>de</strong>pen<strong>de</strong>ntly and cells were<br />

labeled with CD8b and CD45.1 antibodies allowing for the i<strong>de</strong>ntification of the transferred<br />

CD8 OT-I T cells and the d<strong>et</strong>ermination of CFSE intensity.<br />

B. Persistence of antigen<br />

1) Bioluminescence<br />

FVB/N female mice were immunized with 5x10 6 FVB/N-luciferase + male splenocytes. For in<br />

vivo imaging, mice were injected at a given time point with 3mg of D-luciferin (Synchem),<br />

followed by isoflurane inhalation to keep animals sedated during acquisition. Images from<br />

mice were acquired over 10 minutes and the bioluminescent signal was expressed in photon/<br />

s/cm 2 /steradian. For ex vivo imaging, organs were harvested and placed in wells containing<br />

PBS and D-luciferin to d<strong>et</strong>ermine the total bioluminescent signal from each organ; the<br />

bioluminescence is expressed as the total flux/organ in photons/s. Bioluminescence imaging<br />

was performed by using an IVIS Lumina II system (Caliper Life Sciences). Quantification of<br />

the light emission was analyzed using Living Image Software version 3.1 (Xenogen<br />

Corporation).<br />

2) PCR<br />

To investigate the presence of remaining DNA from injected splenocytes, mice were tattooed<br />

around the site of injection prior to immunization. At <strong>de</strong>fined time points, the skin from the<br />

site of immunization was harvested and DNA was extracted using the QIAamp DNA Mini Kit<br />

from Qiagen. PCR was performed on DNA using the primers specific for the ovalbumin gene:<br />

Page 187 of 256

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!